Stimulant Dependence

Co-Chairs: Joseph Palumbo, MD; Thomas Kosten, MD

Objectives: Group will review the cocaine addiction field and the evolution of pharmacotherapies from the animal models, current pharmacotherapies and their relative efficacy, and the industry hurdles to moving those pharmacotherapies to commercialization, with objective of producing a peer reviewed publication.
Next F2F: TBD
Activity History:
Working Group Dinner, 19 February 2013, The Fairmont, Washington, DC
Initial Workshop:
2012 Autumn Conference Stimulant Dependence Workshop
Telecon Schedule: No calls scheduled at this time